Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09, Zacks reports. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%.
Coloplast A/S Price Performance
CLPBY stock opened at $6.75 on Tuesday. The company has a market capitalization of $15.21 billion, a P/E ratio of 35.53, a PEG ratio of 2.56 and a beta of 0.21. Coloplast A/S has a twelve month low of $5.64 and a twelve month high of $9.70. The business has a 50 day simple moving average of $6.82 and a 200-day simple moving average of $6.81. The company has a current ratio of 1.56, a quick ratio of 0.94 and a debt-to-equity ratio of 1.51.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
See Also
- Five stocks we like better than Coloplast A/S
- Check Point’s Turnaround Could Be Closer Than Investors Think
- SpaceX Sent Verizon and T-Mobile Stocks Tumbling—Did Wall Street Overreact?
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
